557 The MI-selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of patients with mild to moderate Alzheimer's disease

✍ Scribed by N. Bodick; W. Offen

• Book ID: 118578100
• Publisher: Elsevier Science
• Year: 1996
• Tongue: English
• Weight: 256 KB
• Volume: 17
• Category: Article
• ISSN: 0197-4580
• DOI: 10.1016/s0197-4580(96)80559-8